Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide MeSH Supplementary Concept Data 2026


MeSH Supplementary
N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide
Unique ID
C521311
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C521311
Entry Term(s)
MK 0364
MK-0364
MK0364
taranabant
Pharm Action
Cannabinoid Receptor Agonists
Registry Numbers
X9U622S114
CAS Type 1 Name
Propanamide, N-((1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)-2-pyridinyl)oxy)-
Heading Mapped to
*Amides
*Pyridines
Frequency
37
Note
MK-0364 is the (1S,2S)-isomer; a cannabinoid-1 receptor inverse agonist; structure in first source
Source
J Pharmacol Exp Ther 2007 Jun;321(3):1013-22
Date Introduced
2007/07/23
Last Updated
2017/08/08
N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide Preferred
MK 0364 Narrower
page delivered in 0.007s